中国P站

Cardiopulmonary Exercise Testing (CPET) is a valuable tool in assessing and managing patients with heart failure and other cardiac conditions. It provides insights into ventilatory efficiency, exercise limitations, and overall prognosis. Ventilatory efficiency, as measured by the VE/VCO2 slope, is a predictor of adverse cardiac events and mortality [1].

CPET helps distinguish between cardiac and pulmonary limitations to exercise [2].

Exercise training can improve ventilatory efficiency and reduce the VE/VCO2 slope in patients with heart failure, with interval training potentially being more effective than continuous training [3].

Pharmacological interventions targeting neurohormonal activation can also improve ventilatory efficiency in heart failure [4].

The VE/VCO2 slope is independently associated with an increased risk of sudden cardiac death in patients with heart failure [5].

CPET can guide individualized exercise prescriptions for cardiac rehabilitation programs [6].

The use of CPET is expanding in the evaluation of patients with congenital heart disease, providing valuable information about functional capacity and prognosis [7].

Early identification of ventilatory inefficiency through CPET may allow for earlier interventions to improve outcomes in patients at risk for cardiac events [8].

CPET-derived parameters, like peak VO2 and VE/VCO2, offer incremental prognostic value beyond traditional clinical assessments in heart failure [9].

Ventilatory efficiency during exercise is impaired in individuals with diabetes and cardiovascular disease, potentially contributing to poorer outcomes [10].

Description

Cardiopulmonary Exercise Testing (CPET) is a comprehensive assessment tool used in cardiology to evaluate a patient's functional capacity and identify the underlying causes of exercise intolerance. It involves monitoring various physiological parameters during exercise, such as oxygen uptake, carbon dioxide production, and ventilatory responses. By analyzing these parameters, clinicians can gain valuable insights into the cardiovascular and respiratory systems' responses to exercise [1].

One of the key parameters assessed during CPET is ventilatory efficiency, which is often quantified by the VE/VCO2 slope. The VE/VCO2 slope represents the relationship between minute ventilation (VE) and carbon dioxide production (VCO2) during exercise. An elevated VE/VCO2 slope indicates ventilatory inefficiency, which is associated with adverse outcomes in patients with heart failure and other cardiovascular conditions. CPET helps differentiate cardiac from pulmonary limitations to exercise, making it a valuable tool for diagnosis and management [2].

Exercise training has been shown to improve ventilatory efficiency and reduce the VE/VCO2 slope in patients with heart failure. Interval training may be more effective than continuous training in achieving these improvements. Pharmacological interventions targeting neurohormonal activation can also improve ventilatory efficiency in heart failure. Furthermore, CPET-derived parameters, such as peak VO2 and VE/VCO2, offer incremental prognostic value beyond traditional clinical assessments in heart failure, aiding in risk stratification [3].

CPET plays a crucial role in guiding individualized exercise prescriptions for cardiac rehabilitation programs. Additionally, its use is expanding in the evaluation of patients with congenital heart disease, providing valuable information about functional capacity and prognosis. Early identification of ventilatory inefficiency through CPET may allow for earlier interventions to improve outcomes in patients at risk for cardiac events. Ventilatory efficiency during exercise is impaired in individuals with diabetes and cardiovascular disease, potentially contributing to poorer outcomes, further highlighting the importance of CPET in identifying and addressing these issues [4].

In heart failure patients with preserved ejection fraction, CPET improves risk stratification. CPET-derived parameters, like peak VO2 and VE/VCO2, offer incremental prognostic value beyond traditional clinical assessments in heart failure [9]. Ventilaroty efficiency during exercise is impaired in individuals with diabetes and cardiovascular disease, potentially contributing to poorer outcomes [10].

Conclusion

Cardiopulmonary Exercise Testing (CPET) is a valuable tool for assessing ventilatory efficiency and overall prognosis in patients with heart failure and other cardiac conditions. An elevated VE/VCO2 slope, indicative of ventilatory inefficiency, is a predictor of adverse cardiac events and mortality. CPET helps differentiate cardiac from pulmonary limitations to exercise. Exercise training, particularly interval training, and pharmacological interventions can improve ventilatory efficiency. VE/VCO2 slope is independently associated with increased risk of sudden cardiac death in patients with heart failure. CPET can guide individualized exercise prescriptions for cardiac rehabilitation programs and provides valuable information in congenital heart disease. Early identification of ventilatory inefficiency through CPET may allow for earlier interventions. CPET-derived parameters offer incremental prognostic value beyond traditional clinical assessments in heart failure. Ventilatory efficiency is impaired in individuals with diabetes and cardiovascular disease.

• Ronald A, Carl JL, Robert VM (2019) .Expert Rev Cardiovasc Ther 17:349-357.

, ,

• Marco G, Volker A, Veerle C (2016) .Eur Heart J 37:2904-2961.

, ,

• Neil AS, Barbara AH, Laura J (2013) .J Card Fail 19:84-94.

, ,

• Piotr P, Adriaan AV, Stefan DA (2016) .Eur Heart J 37:2129-2200.

, ,

• Umberto C, Massimo P, Nicola V (2018) .Eur J Prev Cardiol 25:369-377.

, ,

• Steven JK, Clinton AB, Paul DS (2017) Exercise Testing and Prescription.Wolters Kluwer None:None.

Indexed at, ,

• Ahmar K, Stephanie N, William EE (2017) .Int J Cardiol 227:741-748.

, ,

• Riccardo W, Leandro dM, Martina C (2023) .J Clin Med 12:1045.

, ,

• Gerald P, Bernhard D, Michael F (2019) .ESC Heart Fail 6:1214-1222.

, ,

• Jerome LF, Darcy EF, Mark JH (2019) .J Am Geriatr Soc 67:169-177.

, ,